Table 5.

GLS (%) parameters per vessel

	LAD disease (+)	LAD disease (−)	p-value
Rest	−21.86 ± 3.09	−23.20 ± 2.87	0.03
Peak dose	−16.38 ± 5.76	−24.96 ± 4.42	<0.001
Delta	−5.46 ± 5.27	1.76 ± 3.77	<0.001
	LCX disease (+)	LCX disease (−)
Rest	−19.80 ± 3.16	−21.70 ± 2.88	0.01
Peak dose	−16.13 ± 4.53	−23.43 ± 3.69	<0.001
Delta	−3.59 ± 4.91	1.51 ± 4.14	<0.001
	RCA disease (+)	RCA disease (−)
Rest	−18.73 ± 3.052	−20.23 ± 2.87	0.04
Peak dose	−15.69 ± 5.96	−22.11 ± 4.21	<0.001
Delta	−3.47 ± 5.22	1.65 ± 4.17	<0.001
	LCX-RCA disease (+)	LCX-RCA disease (−)
Rest	−19.28 ± 2.10	−20.29 ± 2.33	0.03
Peak dose	−16.43 ± 5.30	−22.42 ± 3.95	<0.001
Delta	−2.83 ± 5.11	2.18 ± 3.95	<0.001